| Patent application number | Description | Published |
|---|
| 20080299019 | System and process for upgrading heavy hydrocarbons - A system and process for upgrading hydrocarbons such as heavy oils includes high temperature plasma reactor apparatus, in one or more vessels, into which the oils are introduced along with water, such as steam, to produce lighter hydrocarbon fractions, along with carbon monoxide and hydrogen, that flows to an additional stage where more hydrocarbons and water are introduced for further fractionating reactions facilitated by reaction of carbon monoxide and water to produce carbon dioxide and nascent, or prompt, free radicals of hydrogen. Heavy hydrocarbons upgraded can include heavy oils in the form of tar sands, oil shale, and oil residuals. The vessel or vessels can each contain a carbonaceous bed facilitating the described reactions and example embodiments include one vessel with the reactions performed in a single bed and, also, two vessels with the reactions performed in a carbonaceous bed portion in each vessel. | 12-04-2008 |
| 20100199560 | Plasma gasification reactor - A plasma gasification reactor vessel having a top section with a conical wall extending up from a bottom section, containing a carbonaceous bed into which plasma is injected by plasma torches, to a roof of the vessel is arranged in ways that can contribute to characteristics of gas flow and solids residence time that are favorable for thoroughness of reactions and yield of useful reactions products. In some cases, such a conical wall is combined in arrangements with other features such as one or more feed ports arranged to give more uniform distribution including examples with a feed port that has a distributive feed mechanism. The roof of the vessel, in some examples, has vertical outlet ports that include intrusions into the interior volume of the reactor proximate the conical wall of the top section. The configurations of outlet ports with intrusions and the configurations of feed ports for more uniform distribution of feed material are also applicable to reactor vessels with other geometries. | 08-12-2010 |
| 20100215554 | System and process for upgrading heavy hydrocarbons - A system and process for upgrading hydrocarbons such as heavy oils includes a high temperature plasma reactor apparatus, in one or more vessels, into which the oils are introduced along with water, such as steam, to produce lighter hydrocarbon fractions, along with carbon monoxide and hydrogen, that flows to an additional stage where more hydrocarbons and water are introduced for further fractionating reactions facilitated by reaction of carbon monoxide and water to produce carbon dioxide and nascent, or prompt, free radicals of hydrogen. Heavy hydrocarbons upgraded can include heavy oils in the form of tar sands, oil shale, and oil residuals. The vessel or vessels can each contain a carbonaceous bed facilitating the described reactions and example embodiments include one vessel with the reactions performed in a single bed and, also, two vessels with the reactions performed in a carbonaceous bed portion in each vessel. | 08-26-2010 |
| Patent application number | Description | Published |
|---|
| 20090285753 | Novel haptotactic peptides - Novel cell attachment peptides having sequences homologous to specific portions of the carboxy terminal sequence of fibrinogen chains are disclosed. The novel peptides, derived from proteins related to fibrinogen including a peptide adjacent to fibrinogen γ-chain C terminus denoted pre-Cγ possess cell attraction activities, and are useful in pharmaceutical compositions. | 11-19-2009 |
| 20100210544 | PEPTIDES AND PHARMACEUCAL COMPOSITIONS FOR TREATING CONNECTIVE TISSUE - Provided is a pharmaceutical composition for sequestering cells in connective tissue. The composition includes a biocompatible scaffolding to which one or more peptides or proteins are linked. The peptides or proteins have an amino acid sequence that is a subsequence of human ficolin and are capable of binding the cells to be sequestered. The pharmaceutical composition can be used in the treatment of connective tissue, and can be used as a dermal filler. | 08-19-2010 |
| 20100331254 | PULVERIZED FIBRIN CLOTS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM - Provided is a pulverized fibrin clot and a pharmaceutical composition including a pulverized fibrin clot. The pharmaceutical composition may contain the pulverized fibrin clot suspended in a gel such as cross-linked hyaluronic acid. The pharmaceutical composition may be in a form suitable for injection and may be used, for example, in the treatment of connective tissue, such as skin connective tissue. Also provided is a method for preparing a pulverized fibrin clot as well as a method for treating connective tissue using the pharmaceutical composition. | 12-30-2010 |
| 20110111003 | STABLE CELL BINDING CHIMERIC PEPTIDES - The present invention relates to novel family of homologous cell attachment chimeric peptides. In particular, the present invention relates to chimeric peptides, each comprising synthetic peptides comprising (a) an M-tide comprising an amino acid sequence that is at least 80% homologous to the amino acid sequence selected from the group consisting of: SEQ ID NO:1, 2 and 37; and (b) a core haptide comprising an amino acid sequence homologous to amino acid sequences at the carboxy termini of the and E chains of fibrinogen or other proteins comprising C-termini that are homologous to said fibrinogen sequences, wherein the M-tide and the core haptide originate from the same protein. The synthetic peptides are linked to one another thereby providing the chimeric peptides of the invention which does not occur in the native protein as a continuous sequence. The present invention further discloses pharmaceutical compositions comprising said chimeric peptides and uses thereof. | 05-12-2011 |
| 20110123629 | TARGETING OF INNATE IMMUNE RESPONSE TO TUMOR SITE - The invention provides microparticles or nanoparticles for treatment of tumors comprising: (i) a targeting agent to the tumor or the tumor environment; and (ii) at least one inducer that stimulates a desired immune response in the tumor environment, leading to tumor apoptosis, wherein components (i) and (ii) are non-covalently or covalently attached to the surface of said microparticles or nanoparticles. The targeting agent is an agent that recognizes and binds to an antigen, a receptor or other molecules found on the surface of tumor cells or in the tumor environment and are preferably antibodies. | 05-26-2011 |
